China seeks to expand API trade with India

04/29/2013 | PharmaBiz.com (India)

India has become China's top market for active pharmaceutical ingredients, now estimated at almost $2 billion annually, or almost 15% of its API exports, and many Chinese pharma companies are eager to expand that trade. "China should adopt the high standards of quality and also look to making strides in the generic industry here," said Shi Shengyi, speaking for the China National Pharmaceutical Group Corp., Sinopharm.

View Full Article in:

PharmaBiz.com (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL